<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">839235</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2022.839235</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: miR-193a-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 via Epithelial-Mesenchymal Transition Pathway Under Decidua Defect Conditions</article-title>
<alt-title alt-title-type="left-running-head">Li et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Corrigendum: miR-193a-3p Mediates PAS via EFNB2</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Na</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hou</surname>
<given-names>Rui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Tian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Caixia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/772304/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wei</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/766970/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Obstetrics and Gynecology</institution>, <institution>Shengjing Hospital of China Medical University</institution>, <addr-line>Shenyang</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Key Laboratory of Maternal-Fetal Medicine of Liaoning Province</institution>, <institution>Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province</institution>, <addr-line>Benxi</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/129147/overview">Yasuhito Ishigaki</ext-link>, Kanazawa Medical University, Japan</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Caixia Liu, <email>liucxshimen@163.com</email>; Jun Wei, <email>weij@sj-hospital.org</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>839235</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Li, Hou, Yang, Liu and Wei.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Li, Hou, Yang, Liu and Wei</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front Endocrinol (Lausanne)" journal-id-type="nlm-ta" xlink:href="10.3389/fmolb.2020.613802" ext-link-type="doi">A corrigendum on <article-title>miR-193a-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 via Epithelial-Mesenchymal Transition Pathway Under Decidua Defect Conditions</article-title> by Li, N., Hou, R., Yang, T., Liu, C., and Wei, J.&#x20;(2021). Front. Mol. Biosci. 7:613802. doi:<object-id>10.3389/fmolb.2020.613802</object-id>
</related-article>
<kwd-group>
<kwd>miR-193a-3p</kwd>
<kwd>EFNB2</kwd>
<kwd>epithelial-mesenchymal transition</kwd>
<kwd>decidua defect</kwd>
<kwd>placenta accreta spectrum</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>In the original article, there was a mistake in <xref ref-type="fig" rid="F4">Figure&#x20;4</xref> as published. The picture of &#x201c;Control&#x201d; in <xref ref-type="fig" rid="F4">Figure&#x20;4C</xref> was wrong when we upload the pictures. The corrected <xref ref-type="fig" rid="F4">Figure&#x20;4</xref> appears&#x20;below.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>EFNB2 downregulation promotes the migration and invasion of HTR-8/SVneo cells. <bold>(A)</bold> EFNB2 mRNA expression examined after transfection of HTR-8/SVneo cells with siRNA for EFNB2. <bold>(B)</bold> Levels of EFNB2 and EMT-related proteins detected after 48-h transfection. <bold>(C,D)</bold> Transwell migration and invasion assays showing higher numbers of migrated and invaded cells in the si-EFNB2 group than in the NC group (&#xd7;200). All data are presented as the mean&#x20;&#xb1; standard deviation. EFNB2, Ephrin-B2; Si, siRNA; NC, negative control; EMT, epithelial-mesenchymal transition. &#x2a;<italic>P</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic>&#x20;&#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>P</italic>&#x20;&#x3c; 0.001, and &#x2a;&#x2a;&#x2a;&#x2a;<italic>P</italic>&#x20;&#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fmolb-09-839235-g004.tif"/>
</fig>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec sec-type="disclaimer" id="s1">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>